ArticleInflammopharmacology2021

Long noncoding RNA intersectin 1-2 gradually declines during adalimumab treatment, and its reduction correlates with treatment efficacy in patients with ankylosing spondylitis.

Mingwu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.